Genetic Engineering Genetics Reagent Scientist 
Drug Discovery World
FEBRUARY 15, 2023
Genetically modified T cells stimulated with IL2 are now administered as cell therapy for multiple cancer cell types with beneficial results 3,4. Genetically engineered mouse models (GEMM) recapitulate the stromal biology of different human cancers including the tumour microenvironment that regulates the disease process.
Drug Discovery World
MARCH 13, 2023
Before 2019, CGT drug developers still had a young, academic mindset, ordering reagents, materials, and equipment haphazardly and assuming they would show up when needed. About the author Lauren Collison is an established scientist and researcher with over 15 years of experience in cellular immunology. August 2020. April 4, 2022.
Expert insights. Personalized for you.
52 
Let's personalize your content